
Radiation Oncology Program
The UCSF Radiation Oncology Program is among the nation's best for patients who require radiation therapy. We match you with a team of experts on your particular cancer and the best techniques for treating it. Along with UCSF's advanced technologies and our safe care practices, this expertise enables us to provide patients with the best possible outcomes.
We specialize in using high-dose, precisely targeted X-rays to shrink or eliminate tumor cells with minimal damage to surrounding healthy tissues. Depending on the patient, the goal is to destroy cancer, keep it from spreading, or improve quality of life by relieving pain and other symptoms.
Alongside our commitment to outstanding patient care, our team is dedicated to finding safer and more effective cancer therapies through research. Interested patients may have the opportunity to receive promising experimental treatments by joining a clinical trial.
For information on what to expect during your first appointment, how to prepare for your visits and more, please see our FAQ.
Learn more about clinical trials and how they work.
Doctor referral required
Our locations (5)
Our team
-
Mekhail Anwar
MD, PhD
Radiation Oncology -
Steve Braunstein
MD, PhD
Radiation Oncology -
Jason Chan
MD
Radiation Oncology -
Mary Feng
MD
Radiation Oncology -
Christine Glastonbury
MD
-
Julian Hong
MD, MS
Radiation Oncology -
Alexandra Hotca-Cho
MD
Radiation Oncology -
I-Chow (Joe) Hsu
MD
Radiation Oncology -
Natalie Olsen
NP, MSN
Radiation Oncology -
Catherine C. Park
MD
Radiation Oncology, Lymphoma -
Steven Seyedin
MD
Radiation Oncology -
Lisa Singer
MD, PhD
Radiation Oncology -
Matt Susko
MD
Diagnostic Radiology, Radiation Oncology -
Harish N. Vasudevan
MD, PhD
Radiation Oncology -
Anthony C. Wong
MD, PhD
Radiation Oncology -
Sue Yom
MD, PhD
Radiation Oncology, Otolaryngology -
Emi Yoshida
MD
Radiation Oncology
-
Jesse Alexander
MD, PhD
Radiation Oncology -
Jason Chan
MD
Radiation Oncology -
Alexander R. Gottschalk
MD, PhD
Radiation Oncology -
I-Chow (Joe) Hsu
MD
Radiation Oncology -
Kavita K. Mishra
MD
Radiation Oncology -
Nicolas Prionas
MD, PhD
Radiation Oncology -
Mack Roach III
MD
Radiation Oncology -
Lisa Singer
MD, PhD
Radiation Oncology -
Matt Susko
MD
Diagnostic Radiology, Radiation Oncology -
Harish N. Vasudevan
MD, PhD
Radiation Oncology -
Sue Yom
MD, PhD
Radiation Oncology, Otolaryngology
-
Lauren Boreta
MD
Radiation Oncology -
Steve Braunstein
MD, PhD
Radiation Oncology -
Jessica Chew
MD
Radiation Oncology -
Christine Glastonbury
MD
-
S. John Liu
MD, PhD
Radiation Oncology -
Jean L. Nakamura
MD
Radiation Oncology -
David R. Raleigh
MD, PhD
Radiation Oncology -
Penny K. Sneed
MD
Radiation Oncology -
Matt Susko
MD
Diagnostic Radiology, Radiation Oncology -
Harish N. Vasudevan
MD, PhD
Radiation Oncology -
Emily C. Yee
NP
Radiation Oncology
Clinical trials
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
PFS is defined as the proportion of participants alive without progression of disease from the first day of radiotherapy to progression or death by any cause, whichever occurs first, assessed up to 2 years after the last day of ra...
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA...
Blinded Independent Review Committee (BIRC) assessed Metastasis Free Survival (MFS) is defined as the time from randomization to first evidence of radiographically detectable bone or soft tissue distant metastasis by conventional ...
Recruiting
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meni...
Percentage of patients who are progression-free at the landmark of 12 months from start of treatment based on the target lesion(s) that are receiving radiation treatment will be reported. Tumor progression will be assessed using I...
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of...
Nephrectomy and radiographic progression-free survival time is defined as time from randomization to the date of first radiographic progression, nephrectomy, death, or last negative evaluation (censored). nrPFS rates are estimated...
Recruiting
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Proportion of patients who achieve as their best overall response according to Response Evaluation Criteria in Solid Tumors (RECIST) v. 1.1 criteria: Stable disease (SD), partial response (PR), confirmed Complete Response (CR), or...
Recruiting
U.S. News rankings
-
Among the top hospitals in the nation
-
Best in California and No. 7 in the nation for cancer care
Accreditations & memberships
-
National Cancer Institute
The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
-
Commission on Cancer
UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
-
National Comprehensive Cancer Network
UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Support services
Plan your visit
What to Bring
- Medical records (must be received two weeks prior to appointment)
- List of current medications, dosages and prescribing doctors
- List of any other doctors involved in your care
Our research initiatives
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.